Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04967885 |
Other study ID # |
10836 |
Secondary ID |
5P30DA029926 |
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
June 8, 2021 |
Est. completion date |
December 31, 2021 |
Study information
Verified date |
March 2023 |
Source |
Trustees of Dartmouth College |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This study will develop an ecological momentary implementation intentions intervention
(EMI-II) for cigarette smoking, which will link critical situations where smoking is likely
to occur with alternative responses to support avoidance of cigarette use. Using ecological
momentary assessment (EMA) for data collection, this project will evaluate the feasibility,
acceptability, and initial effectiveness of a micro-randomized trial (MRT) of EMI-II
targeting cigarette smoking reduction in a sample of adults who smoke a minimum of 15
cigarettes per day (n=100).
Description:
Cigarette smoking accounts for nearly 1 in 5 preventable deaths in the United States, and
reducing cigarette smoking has been suggested for those not yet ready to quit. Cigarette
reduction has been shown to longitudinally predict eventual cessation. Evidence suggests that
smoking is highly sensitive to environmental stimuli, so ecological momentary interventions
(EMI) embedded within daily life may help reduce cigarette smoking. Within the context of
EMIs, researchers have explored different strategies to support smoking cessation and
reduction. Implementation interventions (II) is a novel self-regulatory strategy that may
help individuals reduce smoking. In II, individuals identify critical situations where
smoking is likely to occur, then develop and plan appropriate alternative responses to avoid
cigarette use. When II is delivered as a brief, single session intervention, II increases
cessation rates relative to control conditions. Although II is well-suited for EMI because
the brief messages are designed to be contextually relevant, no known research has evaluated
whether repeated administration of II delivered by EMI reduces cigarette use. EMI-II may be
beneficial with greater exposure and when delivered in the contexts where a behavior, such as
smoking, is likely to occur.
This randomized controlled trial aims to test an ecological momentary implementation
intentions intervention (EMI-II) to reduce cigarette smoking. This research seeks to identify
in-the-moment intervention components that target momentary contextual and personal variables
to effectively reduce cigarette smoking. Adults who smoke and are interested in reducing
their cigarette use will be randomized to either the immediate intervention condition, or to
a waitlist control. All participants will be followed for one month and will complete weekly
surveys. Intervention participants will receive two weeks of the EMI-II with daily ecological
momentary assessments (EMAs) in the two weeks post-randomization. Waitlist control
participants will complete the weekly surveys for two weeks, then have access to the EMI-II
with daily EMAs for two weeks. The daily EMAs are brief surveys in which participants report
their current context and recent behavior and events.
This project consists of two primary aims:
Aim 1. To test the feasibility and acceptability of a customized, micro-randomized trial
using EMI-II for smoking reduction.
The investigators hypothesize that at least 75% of participants who start the EMI-II
component will complete the two-week active study period. Also, the investigators hypothesize
that participants will rate the acceptability of the EMI-II at least a 3.5 out of 5, on
average.
Aim 2. Test the initial effectiveness of EMI-II for reducing cigarette smoking.
The investigators hypothesize that participants receiving EMI-II will show greater reductions
in self-reported smoking than participants assigned to an EMA-only control. In addition, the
investigators hypothesize that self-reported cigarette smoking during the next EMA following
EMI-II presentation will be lower, relative to cigarette smoking reported in EMAs that do not
proximally follow the EMI-II delivery.